The Structural Disease Center

Filter Your Results




Abbott's Amplatzer Piccolo Occluder Approved to Treat Patent Ductus Arteriosus in Premature Babies and Newborns

January 14, 2019 -- Abbott Structural Heart announced that the FDA has approved the company's Amplatzer Piccolo occluder, which can be implanted in very small babies (weig…

FDA Approves Edwards’ Sapien 3 Ultra TAVR System

January 4, 2019 -- Edwards Lifesciences announced FDA approval for its Sapien 3 Ultra system for transcatheter aortic valve replacement (TAVR) in patients with severe symptoma…

Venus Medtech and Keystone Heart Complete Merger

December 27, 2018 -- Venus Medtech announced it has completed its merger with Keystone Heart, Ltd. Venus Medtech is a leading transcatheter heart valve company in China. Keyst…

Boston Scientific Acquires Millipede

December 27, 2018 -- Boston Scientific Corporation announced that it has acquired Millipede, Inc., a privately held company in Santa Rosa, California, in an approximately $325…

FDA Approves Expansion of IDE Trial of the JenaValve TAVR System

December 3, 2018 -- JenaValve Technology, Inc. announced the FDA has approved expansion of its investigational device exemption (IDE) feasibility studies for the JenaValve per…

CLASP IID Trial Evaluates Edwards' Pascal Transcatheter Mitral Valve Repair System

December 3, 2018 -- Atlantic Health System’s Morristown Medical Center announced that the first transcatheter mitral valve repair (TMVR) procedure in the CLASP IID pivot…

One-Year Data Published From FORWARD Study of Medtronic's CoreValve Evolut R System

December 3, 2018 -- Ganesh Manoharan, MD, et al published 1-year outcomes from the international FORWARD study in Journal of the American College of Cardiology (JACC): Cardiov…

Five-Year Outcomes Published for Medtronic's CoreValve TAVR System in High-Risk Patients

November 26, 2018 -- The 5-year outcomes from the randomized United States pivotal high-risk trial of the CoreValve transcatheter aortic valve replacement (TAVR) system (Medtr…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.